Search

everythinglearnresearchcommunity

for

Search:↓

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Erlotinib can cause excessive eyelash growth.

Nephronectin is linked to worse breast cancer outcomes and helps cancer spread.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.